NURIX THERAPEUTICS INC's ticker is and the CUSIP is 67080M903. A total of 2 filers reported holding NURIX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22 | -35.3% | 2,900 | -17.1% | 0.00% | – |
| Q2 2023 | $34 | +325.0% | 3,500 | +250.0% | 0.00% | – |
| Q1 2023 | $8 | +700.0% | 1,000 | +900.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 100 | -50.0% | 0.00% | – |
| Q3 2022 | $2,000 | -97.5% | 200 | -92.9% | 0.00% | – |
| Q4 2021 | $81,000 | +1250.0% | 2,800 | +139900.0% | 0.00% | – |
| Q1 2021 | $6,000 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,300 | $16,000 | 0.00% |